David Arkowitz - 21 Nov 2024 Form 4 Insider Report for iBio, Inc. (IBIO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IBIO	Stock Option (right to buy)	Award	$0	+12,600		$0.000000	12,600	21 Nov 2024	Common Stock	12,600	$2.45	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These options vest pro rata on a monthly basis over three years commencing on the date of the grant.